Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1964 1
1975 1
1978 2
1979 1
1980 3
1982 1
1983 4
1984 4
1985 1
1986 5
1989 2
1990 2
1991 3
1992 4
1993 4
1994 13
1995 9
1996 9
1997 9
1998 6
1999 9
2000 9
2001 7
2002 9
2003 8
2004 12
2005 10
2006 7
2007 9
2008 12
2009 18
2010 19
2011 15
2012 18
2013 28
2014 31
2015 26
2016 26
2017 41
2018 27
2019 30
2020 35
2021 35
2022 43
2023 30
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

541 results

Results by year

Filters applied: . Clear all
Page 1
Giant cell tumour of bone.
Aoude A, Nikomarov D, Perera JR, Ibe IK, Griffin AM, Tsoi KM, Ferguson PC, Wunder JS. Aoude A, et al. Bone Joint J. 2023 May 1;105-B(5):559-567. doi: 10.1302/0301-620X.105B5.BJJ-2022-1231.R1. Bone Joint J. 2023. PMID: 37121582
For patients treated by curettage, only age less than 30 years (p = 0.042) and location in the distal radius (p = 0.043) predicted higher LR. The rate of LR did not differ whether cement or bone graft was used (p = 0.753), but may have been reduced by the use of hydrogen p …
For patients treated by curettage, only age less than 30 years (p = 0.042) and location in the distal radius (p = 0.043) predicted hi …
Updated concepts in treatment of giant cell tumor of bone.
van der Heijden L, Lipplaa A, van Langevelde K, Bovée JVMG, van de Sande MAJ, Gelderblom H. van der Heijden L, et al. Curr Opin Oncol. 2022 Jul 1;34(4):371-378. doi: 10.1097/CCO.0000000000000852. Curr Opin Oncol. 2022. PMID: 35837707 Review.
The most frequent mutation (G34W) can be detected using immunohistochemistry and is highly specific in differentiating GCTB from other giant cell containing tumors. PD-L1 expression can be used as biological marker to predict higher recurrence risks in GCTB patients.The us …
The most frequent mutation (G34W) can be detected using immunohistochemistry and is highly specific in differentiating GCTB from other giant …
Giant cell tumor of bone in an eighteenth-century Italian mummy.
Ventura L, Petrella E, Piciucchi S, Cilli E, Luiselli D, Feeney RNM, Traversari M. Ventura L, et al. Virchows Arch. 2021 Dec;479(6):1255-1261. doi: 10.1007/s00428-021-03192-5. Epub 2021 Aug 30. Virchows Arch. 2021. PMID: 34462806 Free PMC article.
The study of this type of neoplasm in antiquity can be used as a means to better understand its characteristics and behavior and to expand the depth of time of the etiology of these lesions. We report a case of GCT of the left femur observed following the total body CT ima …
The study of this type of neoplasm in antiquity can be used as a means to better understand its characteristics and behavior and to expand t …
Giant cell tumor of bone: current treatment options.
Skubitz KM. Skubitz KM. Curr Treat Options Oncol. 2014 Sep;15(3):507-18. doi: 10.1007/s11864-014-0289-1. Curr Treat Options Oncol. 2014. PMID: 24788576 Review.
Giant cell tumor of bone (GCTB) comprises up to 20 % of benign bone tumors in the US. ...The optimal length of treatment and schedule of denosumab is unknown, but recurrences after apparent complete responses have been observed after stop …
Giant cell tumor of bone (GCTB) comprises up to 20 % of benign bone tumors in the US. ...The optimal leng …
Giant cell tumor of bone.
Yasko AW. Yasko AW. Curr Oncol Rep. 2002 Nov;4(6):520-6. doi: 10.1007/s11912-002-0067-2. Curr Oncol Rep. 2002. PMID: 12354366 Review.
Giant cell tumor of bone is an enigmatic osseous neoplasm that is histologically benign but clinically shows local aggression and metastatic potential. The absence of clinical, radiographic, or pathologic features that are predictive of t …
Giant cell tumor of bone is an enigmatic osseous neoplasm that is histologically benign but clinically sh …
Secondary Malignancy in Giant Cell Tumor: A Single-Center Study.
Joo MW, Lee YS, Park HS, Chung YG, Yoon C. Joo MW, et al. Curr Oncol. 2022 Jun 2;29(6):4068-4080. doi: 10.3390/curroncol29060324. Curr Oncol. 2022. PMID: 35735433 Free PMC article. Review.
Giant cell tumor of bone (GCTB) undergoes a sarcomatous transformation. ...Benign recurrence occurred in five GCTB patients not treated with radiotherapy. No pulmonary implants were observed. The median latency to the malignant transforma …
Giant cell tumor of bone (GCTB) undergoes a sarcomatous transformation. ...Benign recurrence occurred in …
Locally Aggressive Connective Tissue Tumors.
Gounder MM, Thomas DM, Tap WD. Gounder MM, et al. J Clin Oncol. 2018 Jan 10;36(2):202-209. doi: 10.1200/JCO.2017.75.8482. Epub 2017 Dec 8. J Clin Oncol. 2018. PMID: 29220303 Free PMC article. Review.
In this review, we highlight the complexities of the natural history, biology, and clinical management of three intermediate connective tissue tumors: desmoid tumor (DT) or aggressive fibromatosis, tenosynovial giant cell tumor (TGCT) or diffuse-type pigmented villonodular synovi …
In this review, we highlight the complexities of the natural history, biology, and clinical management of three intermediate connective tiss …
Malignant giant cell tumour of bone: a review of clinical, pathological and imaging features.
Tahir I, Andrei V, Pollock R, Saifuddin A. Tahir I, et al. Skeletal Radiol. 2022 May;51(5):957-970. doi: 10.1007/s00256-021-03913-6. Epub 2021 Sep 25. Skeletal Radiol. 2022. PMID: 34562125 Review.
Primary malignant giant cell tumour of bone occurs when sarcomatous tissue is observed within conventional giant cell tumour histologically on initial presentation. ...
Primary malignant giant cell tumour of bone occurs when sarcomatous tissue is observed within conventional giant cell tumour histolog …
Giant cell tumor of bone - Analysis of 213 cases involving extra-craniofacial bones.
Konishi E, Outani H, Mano M, Nagata S, Shirai T, Naka N, Hori Y, Takenaka S, Haga H, Toguchida J, Kakunaga S, Kuwae Y, Hoshi M, Inoue T, Aono M, Morinaga Y, Nakashima Y. Konishi E, et al. Pathol Int. 2021 Aug;71(8):500-511. doi: 10.1111/pin.13107. Epub 2021 Jun 14. Pathol Int. 2021. PMID: 34125982 Free PMC article.
We elucidated clinicopathological characteristics of giant cell tumor of bone (GCTB) in Japan, and significant clinicopathological factors for predicting local recurrence. ...Denosumab administration increases risk but not significantly ( …
We elucidated clinicopathological characteristics of giant cell tumor of bone (GCTB) in Japan, and signif …
Treatment of giant cell tumors of the distal radius: A long-term patient-reported outcomes study.
Kuruoglu D, Rizzo M, Rose PS, Moran SL, Houdek MT. Kuruoglu D, et al. J Surg Oncol. 2022 Sep;126(4):798-803. doi: 10.1002/jso.26967. Epub 2022 Jun 1. J Surg Oncol. 2022. PMID: 35642908 Review.
Functional outcomes were collected including the Musculoskeletal Tumor Society Score (MSTS), QuickDash, the Visual Analog Scale (VAS), and the Patient Rated Wrist Evaluation (PRWE). ...At most recent follow-up, there was no difference in MSTS, VAS, and PRWE (p > 0.05) b …
Functional outcomes were collected including the Musculoskeletal Tumor Society Score (MSTS), QuickDash, the Visual Analog Scale (VAS) …
541 results